Therapeutics News and Research

RSS

NYU Abu Dhabi researchers develop nanocarrier for more effective cancer drug delivery

A team of researchers at NYU Abu Dhabi has developed a biocompatible, biodegradable, and economical nanocarrier for safer and more effective delivery of anticancer drugs.

3 Mar 2020

Health officials urge India to be on high alert for coronavirus

China has borne the brunt of the coronavirus outbreak with tens of thousands infected and 2,912 deaths related to the coronavirus disease (COVID-19). Now, health officials across the globe are urging India to be on high alert.

2 Mar 2020

Tapping pre-existing immunity to enhance therapeutic cancer treatment

A new research from the University of Helsinki showed for the first time how the pre-immunization acquired through common childhood vaccines can be used to enhance therapeutic cancer treatment.

2 Mar 2020

UK races to tackle coronavirus spread

The coronavirus disease (COVID-19) outbreak spiked dramatically on Sunday, with more countries reporting additional cases. The deadly virus has added 13 more confirmed cases in the United Kingdom, with Scotland reporting its first case. Health officials are racing to identify people who are unaware they may have been exposed.

1 Mar 2020

Coronavirus outbreak is a stark reminder of ongoing challenge of emerging infectious pathogens

The emergence and rapid increase in cases of coronavirus disease 2019 (COVID-19), a respiratory illness caused by a novel coronavirus, pose complex challenges to the global public health, research and medical communities, write federal scientists from NIH's National Institute of Allergy and Infectious Diseases and from the Centers for Disease Control and Prevention.

28 Feb 2020

Gene therapy regenerates functional new neurons in mouse models of HD

Huntington's disease (HD) is a rare disease characterized by abnormal chorea movement and caused by Huntingtin (Htt) gene mutation and neurodegeneration in a brain area called striatum.

28 Feb 2020

Boehringer Ingelheim and Trutino enter into research collaboration to advance cytokine therapies

Boehringer Ingelheim and Trutino Biosciences today announced they have entered into a research collaboration and worldwide licensing agreement based on Trutino’s innovative On-Demand-Cytokine platform.

From Boehringer Ingelheim International GmbH 28 Feb 2020

Major investment can help improve technology aimed at turning bad fat to good fat

A significant investment from a Purdue University alumnus and his wife will help further develop technology aimed at treating obesity and diabetes by turning bad fat into good fat inside the body.

28 Feb 2020

Gene-editing technology may lead to new model for studying Parkinson’s disease

Parkinson's disease researchers have used gene-editing tools to introduce the disorder's most common genetic mutation into marmoset monkey stem cells and to successfully tamp down cellular chemistry that often goes awry in Parkinson's patients.

27 Feb 2020

Bifunctional nanobodies with antitoxin potencies could protect against botulinum neurotoxins

New study reveals potential for developing novel antibody-based antitoxins against botulinum neurotoxins (BoNTs), including the most commonly used, yet most toxic one, Botox.

27 Feb 2020

Renishaw completes main part of Phase 1-2 clinical trial along with Herantis Pharma for treatment of Parkinson’s disease

Global engineering technologies company, Renishaw, announces that its award-winning intraparenchymal drug delivery device, has played a critical role in a joint Phase 1-2 clinical study with Herantis Pharma plc, for the investigation of cerebral dopamine neurotrophic factor (CDNF)as a treatment for Parkinson's disease.

27 Feb 2020

UC researchers uncover potential new treatment for patients with metastatic melanoma

Researchers at the University of Cincinnati have uncovered a potentially more beneficial treatment regimen for patients with metastatic melanoma.

26 Feb 2020

Renishaw Announces Completion of the Main Part of a Multi-Centre Clinical Trial Jointly Undertaken with Herantis Pharma plc for the Treatment of Parkinson’s Disease Patients

Renishaw, announces that its drug delivery device has played a critical role in the investigation CDNF as a treatment for Parkinson's disease.

From Renishaw plc - Additive Manufacturing for Healthcare Applications 26 Feb 2020

Genome research collaboration in Finland welcomes Janssen and Maze Therapeutics

FinnGen, a large-scale academic - industry, genome research collaboration in Finland now includes eleven industry partners with the addition of the Janssen Pharmaceutical Companies of Johnson & Johnson and Maze Therapeutics.

25 Feb 2020

Clinical trial to evaluate safety, efficacy of remdesivir in adults with COVID-19 begins

A randomized, controlled clinical trial to evaluate the safety and efficacy of the investigational antiviral remdesivir in hospitalized adults diagnosed with coronavirus disease 2019 (COVID-19) has begun at the University of Nebraska Medical Center in Omaha.

25 Feb 2020

Immunotherapy drug combination effective for patients with fast-growing neuroendocrine tumors

Many patients with rare, fast-growing neuroendocrine tumors respond well to a common immunotherapy drug combination, according to the first peer-reviewed publication out of DART, short for Dual Anti-CTLA-4 and Anti-PD-1 Blockade in Rare Tumors, a unique rare cancer clinical trial.

24 Feb 2020

Researchers discover glial cells that control stress response, extend lifespan in worms

While many of us worry about proteins aggregating in our brains as we age and potentially causing Alzheimer's disease or other types of neurodegeneration, we may not realize that some of the same proteins are aggregating in our muscles, setting us up for muscle atrophy in old age.

23 Feb 2020

Using newly discovered immune cell type to fight pancreatic cancer

Immunotherapy is showing great promise for treating cancer. But so far, this approach has been effective in only about 20% of all cancers. To advance those results, researchers are looking for new ways to mobilize the immune system to destroy tumors.

23 Feb 2020

Isolating Single T-cells of Interest using an Optofluidic Platform

Researchers are in desperate need of single-cell analysis techniques and those that allow the isolation of high-value T-cells for research and development.

From Bruker Cellular Analysis 21 Feb 2020

Administering immunotherapy alongside chemoradiation for advanced NSCLC appears to be safe and tolerable

Research from Rutgers Cancer Institute of New Jersey shows administering the immunotherapy drug pembrolizumab together with chemotherapy given at the same time as radiation treatment (chemoradiation) is safe and tolerable as a first-line therapy for patients with stage 3 non-small cell lung cancer.

21 Feb 2020

Therapeutics News and Research

NYU Abu Dhabi researchers develop nanocarrier for more effective cancer drug delivery

Health officials urge India to be on high alert for coronavirus

Tapping pre-existing immunity to enhance therapeutic cancer treatment

UK races to tackle coronavirus spread

Coronavirus outbreak is a stark reminder of ongoing challenge of emerging infectious pathogens

Gene therapy regenerates functional new neurons in mouse models of HD

Boehringer Ingelheim and Trutino enter into research collaboration to advance cytokine therapies

Major investment can help improve technology aimed at turning bad fat to good fat

Gene-editing technology may lead to new model for studying Parkinson’s disease

Bifunctional nanobodies with antitoxin potencies could protect against botulinum neurotoxins

Renishaw completes main part of Phase 1-2 clinical trial along with Herantis Pharma for treatment of Parkinson’s disease

UC researchers uncover potential new treatment for patients with metastatic melanoma

Renishaw Announces Completion of the Main Part of a Multi-Centre Clinical Trial Jointly Undertaken with Herantis Pharma plc for the Treatment of Parkinson’s Disease Patients

Genome research collaboration in Finland welcomes Janssen and Maze Therapeutics

Clinical trial to evaluate safety, efficacy of remdesivir in adults with COVID-19 begins

Immunotherapy drug combination effective for patients with fast-growing neuroendocrine tumors

Researchers discover glial cells that control stress response, extend lifespan in worms

Using newly discovered immune cell type to fight pancreatic cancer

Isolating Single T-cells of Interest using an Optofluidic Platform

Administering immunotherapy alongside chemoradiation for advanced NSCLC appears to be safe and tolerable

Event guide: The Non-Opioid Pain Therapeutics Summit eBook

Designing fluidic architecture for scalable diagnostic platforms

Evaluating new approaches for rare disease genomics

Expanding access to NMR with the Fourier 80 Duo

Latest News